A detailed history of Calamos Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Calamos Advisors LLC holds 12,069 shares of AZN stock, worth $800,174. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,069
Previous 12,069 -0.0%
Holding current value
$800,174
Previous $941,000 0.11%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$66.81 - $80.83 $5,144 - $6,223
-77 Reduced 0.63%
12,069 $941,000
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $741,270 - $844,997
12,146 New
12,146 $822,000
Q4 2021

Feb 01, 2022

SELL
$54.02 - $63.83 $16 Million - $19 Million
-296,907 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$55.56 - $60.79 $16.5 Million - $18 Million
296,907 New
296,907 $17.8 Million
Q3 2019

Oct 21, 2019

SELL
$40.12 - $45.47 $2.99 Million - $3.38 Million
-74,425 Closed
0 $0
Q2 2019

Aug 07, 2019

SELL
$37.28 - $41.68 $916,156 - $1.02 Million
-24,575 Reduced 24.82%
74,425 $3.07 Million
Q4 2018

Jan 24, 2019

BUY
$36.86 - $41.49 $357,542 - $402,453
9,700 Added 10.86%
99,000 $3.76 Million
Q3 2018

Oct 22, 2018

BUY
$34.76 - $39.72 $3.1 Million - $3.55 Million
89,300 New
89,300 $3.53 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.